Longevity and Wellness
Tesamorelin
A closely reviewed program where approved indications and any proposed program use are clearly separated.
$249/month
All-inclusive program price · Illustrative demonstration pricing
Product. Product imagery is an illustrative demonstration mock-up; labels, lots, and concentrations shown are not real.
Longevity and Wellness
Sermorelin Program
A provider-directed sermorelin program. No promised hormone changes, no body-composition claims — clinical review decides.
$179/month
All-inclusive program price · Illustrative demonstration pricing
- Online licensed-provider review
- Secure medical intake after checkout
- Ongoing program support by secure message
- Standard shipping
- Routine follow-up required by the program
May be compounded — not FDA-approved
3 mg/vial (illustrative demonstration strength)
Limited availability. Endocrine programs may require additional review.
Purchasing a program does not guarantee that a prescription will be issued. If the provider does not approve treatment, the order will be handled according to the ClientRx refund and cancellation policy. Laboratory testing, expedited shipping, replacement products, and third-party services are not included unless specifically stated.
Demonstration notice. ClientRx is a fictional demonstration telehealth brand. Products, pricing, providers, pharmacies, and testimonials shown are illustrative only.
About this program
The ClientRx Sermorelin Program is a provider-directed peptide program in the longevity and wellness category. It is described here in educational terms and is offered only where a licensed clinician determines it is appropriate.
Sermorelin is a growth-hormone-releasing-hormone analogue. Historically it has had recognised diagnostic and clinical uses; its use in wellness contexts is different, and evidence for wellness outcomes is limited.
ClientRx does not promise increased growth hormone, muscle gain, fat loss, improved sleep, or rejuvenation. Clinicians reviewing this program may request laboratory work and may decline treatment.
Because this program touches endocrine pathways, clinicians generally look closely at existing endocrine conditions, cancer history, and current medications before considering it at all.
How it may work
Sermorelin acts at the pituitary on the pathway that governs endogenous growth-hormone release. That is a description of a mechanism, not a prediction of a clinical result.
Whether stimulating that pathway produces a meaningful change for an individual is uncertain and depends on age, baseline endocrine function, and other health factors.
No dosing or self-administration information is published on this website.
Safety summary
- Described effects include injection-site reactions, flushing, headache, dizziness, and changes in appetite.
- Programs affecting endocrine pathways require clinical oversight. Some conditions, including active malignancy, generally exclude use.
- This is a high-level summary. Report any new or unexpected symptom to your care team promptly.
This summary is not a complete list of risks and is not medical advice. Visit the safety center. In an emergency, call 911.
Program questions
ClientRx makes no such promise. Any effect on hormone levels is individual, uncertain, and a matter for clinical assessment.
Related programs
Longevity and Wellness
NAD+
A provider-directed wellness program framed around cellular-energy support, with deliberately cautious claims.
$199/month
All-inclusive program price · Illustrative demonstration pricing
Peptide Programs
CJC-1295
An investigational growth-hormone-releasing peptide shown with a full regulatory disclosure and no outcome claims.
$199/month
All-inclusive program price · Illustrative demonstration pricing